Tumor-derived PRMT1 suppresses macrophage antitumor activity by inhibiting cGAS/STING signaling in gastric cancer cells

8.5
来源: Nature
发布时间: 2025-08-27 03:46
摘要:

PRMT1, an epigenetic regulator, is found to suppress macrophage antitumor activity in gastric cancer by inhibiting the cGAS/STING signaling pathway. Its knockdown promotes M1 macrophage polarization and enhances the antitumor immune response, indicating its potential as a therapeutic target in gastric cancer treatment.

原文: 查看原文

价值分投票

评分标准

新闻价值分采用0-10分制,综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。 评分越高,表示该新闻的价值越大,越值得关注。

价值维度分析

domain_focus

1.0分+1.0

business_impact

0.8分+0.8

scientific_rigor

1.5分+1.5

timeliness_innovation

1.5分+1.5

investment_perspective

2.5分+2.5

market_value_relevance

1.0分+1.0

team_institution_background

0.5分+0.5

technical_barrier_competition

1.0分+1.0

关键证据

PRMT1 knockdown leads to increased infiltration of M1-like macrophages.
Activation of cGAS/STING signaling enhances antitumor immunity.
PRMT1 is associated with poor prognosis in gastric cancer patients.

真实性检查

否

AI评分总结

PRMT1, an epigenetic regulator, is found to suppress macrophage antitumor activity in gastric cancer by inhibiting the cGAS/STING signaling pathway. Its knockdown promotes M1 macrophage polarization and enhances the antitumor immune response, indicating its potential as a therapeutic target in gastric cancer treatment.

评论讨论

发表评论